16 episodes

Conversations with renowned experts shaping the future of healthcare. Listen for insights on MedTech trends and best practices from leadership, innovators and clinicians around the world.
See acast.com/privacy for privacy and opt-out information.

Shaping The Future Of Healthcare Siemens Healthineers

    • Science
    • 4.9 • 8 Ratings

Conversations with renowned experts shaping the future of healthcare. Listen for insights on MedTech trends and best practices from leadership, innovators and clinicians around the world.
See acast.com/privacy for privacy and opt-out information.

    MRI at 50: The Past, Present, and Future of a High-End Imaging Technology

    MRI at 50: The Past, Present, and Future of a High-End Imaging Technology

    Magnetic Resonance Imaging (MRI) has played a big role in shaping the healthcare industry’s approach to detection, monitoring, and tracking of medical conditions. Since its invention in the 1970s, a lot of improvements have been made to increase its performance and accessibility. As the industry continues to digitalize, we can expect more changes that will make MRIs more powerful and efficient.

    The fifty-year history of MRI takes us from early plans scribbled on a napkin at a Pittsburgh Eat n’ Park in 1971, through developments to increase patient comfort and image quality in the 1980s, and into a future where AI can predict, survey, and manage a patient’s likelihood for dementia. In this special episode, Arthur Kaindl talks to experts in the field, Bruce Rosen, M.D., Franz Schmitt, Jürgen Hennig, and Vivek Muthurangu, M.D., about the recent and eventful history of MRI.

    In today’s conversation, you’ll hear about the development of the first MRI machine and the challenges faced by the inventors. You’ll learn about the improvements that have been made and the impact that they’ve had on the healthcare industry, as well as what the future holds for MRI machines and what it’ll take to get there.

    Some Questions Asked:
    Did you think that MRI was going to be a big innovation? (02:52)How did it feel seeing the results of a scan during the development stages? (06:39)What exactly can current MRI scanners help us see now that we couldn't see with earlier scanners? (12:54)When did you really start to see that certain problems in MRI needed fixing? (18:26)What role would you give to artificial intelligence in the future of MRI? (21:51)What have you found MRI clinicians need to do, especially when working with pediatric patients? (26:53)
    What You’ll Learn in This Episode:
    How the first MRI scanner worked (04:15)The purpose of different MRI sounds (09:15)The role of MRI in the detection and tracking of neurodegenerative diseases (14:06)The impact of imaging technology on how we think about law and criminal behavior (16:56)How to make MRI scanners more accessible (24:13)The future of MRI scanners (28:29)
    Connect with Dr. Bruce Rosen:
    LinkedIn
    Connect with Franz Schmitt:
    LinkedIn
    Connect with Jürgen Hennig:
    University Medical Center Freiburg 
    Connect with Dr. Vivek Muthurangu:
    Centre for Translational Cardiovascular Imaging
    Connect with Arthur Kaindl:
    LinkedIn
    Jürgen Hennig and Franz Schmitt received financial support from Siemens Healthineers for this collaboration.

    See acast.com/privacy for privacy and opt-out information.

    • 31 min
    Integrated Diagnostics and the Collaborative Future of Medicine with Prof. Dr. Stefan Schönberg | Christoph Zindel

    Integrated Diagnostics and the Collaborative Future of Medicine with Prof. Dr. Stefan Schönberg | Christoph Zindel

    One of the biggest beneficiaries of technological advancements has been the field of medicine. While vaccines to stop previous pandemics took decades to develop, multiple COVID-19 vaccines were developed within a much shorter time frame. Increased collaboration between players in the industry and those in the tech world promises even more advancements in the near future.

    In this episode, Managing Board Member Christoph Zindel is joined by Stefan Schönberg, MD, director and chairman of the department of radiology and nuclear medicine at the University Medical Center Mannheim. He is former President of the German Roentgen Society and a strong proponent of integrated diagnostics.
    In today’s conversation, you’ll hear about integrated diagnostics and the benefits that come with it. You’ll learn about the advancements that are being made and the existing gaps that need to be closed to take the medical industry to the next level. You’ll also learn about the role that AI has in advancing diagnostics, treatment, and prevention of diseases. Lastly, we’ll discuss the role of data in medical research and the current barriers to federated learning and research.

    Some Questions Asked:
    Can you give us a glimpse of integrated diagnostics at University Hospital in Mannheim? (01:11)Do you see circulating free DNA being used in early cancer detection? (08:39)Do you believe that integrated diagnostic influences therapeutic decisions? (12:33)How do you promote cultural change connected to integrated diagnostics? (21:45)
    What You’ll Learn in This Episode:
    How integrated diagnostic can be used to understand a disease’s trajectory (05:56)What is needed to make integrated diagnostic a success (11:01)The role of the digital twin in integrated diagnostics (16:31)How federated learning evidence can accelerate medical research (18:58)
    Connect with Prof. Dr. Stefan Schönberg:
    University Hospital Mannheim
     
    Connect with our Managing Board Member, Christoph Zindel: 
     LinkedIn
    See acast.com/privacy for privacy and opt-out information.

    • 29 min
    The Importance of Radiology in Developing Nations with Dr. Suresh de Silva | Christoph Zindel

    The Importance of Radiology in Developing Nations with Dr. Suresh de Silva | Christoph Zindel

    Economic disparities around the world are an unfortunate reality. The past year has made it clearer than ever that the availability of quality healthcare for everyone benefits the whole. Globalization has forged a connection that strengthens our sense of humanity. With that sentiment in mind, it’s important that those who can help recognize that they bear a responsibility to lift up the whole. 

    In this episode, Managing Board Member Christoph Zindel talks to Dr. Suresh de Silva, founder of Radiology Across Borders, a global charity that provides education and programs in radiology to help save lives in developing nations. Dr. de Silva is a fellow of the Royal Australian and New Zealand College of Radiologists and also an Adjunct Senior Lecturer at UNSW and an Oncological/Urological radiologist.

    In today’s conversation, you’ll hear about the positive global impact of Dr. Suresh de Silva’s organization, Radiology Across Borders. Their numerous projects are helping not only with treatment, but also with screening and prevention in populations that need greater access to medical technology and care. You’ll also hear important perspectives on the impact and future possibilities of AI in medical care. Additionally, the conversation covers the realities of starting a global charity from the ground up, and delves into the mindset of a founder who has successfully made an impact on countless lives around the world. 

    Some Questions Asked:
    What projects are you currently focused on? (9:21)What's your vision of the role of AI-supported radiology in the future? (17:43)How can other organizations learn from Radiology Across Borders? (26:27)How have you been affected privately and professionally by this pandemic? (34:56)
    What You’ll Learn in This Episode:
    The important role radiology plays in healthcare (4:52)The biggest potential impact of AI (20:51)The realities of creating a charity organization (29:15)Comparing the differences between recent pandemics (37:20)
    Connect with Dr. Suresh de Silva:
    LinkedIn
    Connect with our Managing Board Member, Christoph Zindel: 
     LinkedIn

    See acast.com/privacy for privacy and opt-out information.

    • 42 min
    How Do Coronavirus Variants Affect our Immune System, and How Can We Protect our Vulnerable?

    How Do Coronavirus Variants Affect our Immune System, and How Can We Protect our Vulnerable?

    We’ve come a long way in our understanding of SARS-CoV-2. Since the first cases were reported in late 2019, the rapid spread of the virus required quick thinking, thorough communication across the globe, and immediate action within the medical community. SARS-CoV-2 spread rapidly and began mutating differently all over the world. Tracking, testing, and treatment options had to keep pace. We needed information quickly in order to treat people effectively and protect our most vulnerable. 

    Today, Siemens Healthineers President of Laboratory Diagnostics, Deepak Nath is joined by Dr. Ankur Mutreja, a global health scientist from the University of Cambridge, and Dr. Kevin Latinis, a clinical Rheumatologist with a practice in Missouri. Their experiences throughout the SARS-CoV-2 outbreak will help us understand how the virus continues to mutate globally, why viruses mutate, and how early antibody testing helped us to understand the ability of this virus to spread at such an advanced pace. 

    In this episode, you’ll hear about the known variants of SARS-CoV-2, how our immune systems respond through these mutations, and why names matter. We’ll also rewind back to the beginning of the pandemic and hear about some of the earliest serology tests that took place in a Missouri nursing home, and how that timely information helped us understand how the virus spread. 

    Some Questions Asked:
    What consequences can naming variants after countries or regions have? (2:09)Could a new variant emerge that effectively sets us back to square one? (4:14)How can vaccine development keep pace with these variants? (9:13)Why use antibody tests? (15:18)How can we take care of our most vulnerable? (19:49)What are the next steps for data collection? (22:39)
    What You’ll Learn in This Episode:
    Why new variants of the virus continue to be discovered (2:59)Protection levels against new variants from antibodies and the vaccine (4:54)Why mutations occur and when we need to be concerned about them (5:51)What we learned from an early study of antibodies (14:23)How antibody tests work, and what they can tell us (17:30)How one doctor is helping patients feel comfortable with vaccines (21:02)
    Connect with Ankur Mutreja:
    LinkedIn

    Connect with Kevin Latinis:
    LinkedIn
    Youtube

    Connect with Katherine Soreng:
    LinkedIn

    Connect with Deepak Nath:
    LinkedIn
    Twitter 

    See acast.com/privacy for privacy and opt-out information.

    • 24 min
    Prioritizing Diversity and Inclusion for a Better Workplace with Prof. Dr. Ulrike Attenberger| Christoph Zindel

    Prioritizing Diversity and Inclusion for a Better Workplace with Prof. Dr. Ulrike Attenberger| Christoph Zindel

    Diversity and inclusion are big topics in business today. While it’s something many organizations are striving for, it’s not always understood on a statistical or emotional level. When employees don’t feel as though they’re part of the team, the consequences can mount up to something much bigger. Feeling “apart” takes a toll on not only performance, but also the health of the employee. Likewise, a lack of diversity means a lack of varied experience. This can hold the whole team back, and foster a lack of understanding.

    Healthcare bears a unique responsibility when it comes to fostering an environment of comfort and consideration. Understanding the needs of patients is much more than tending to wounds and performing surgeries. At its core, it’s about empathy. When empathy and understanding exist within the work environment, only then can they effectively translate to the realm of care. 

    In this episode, Managing Board Member Christoph Zindel interviews Prof. Dr. Ulrike Attenberger.  Professor Attenberger is Director of the Clinic for Diagnostic and Interventional Radiology at Bonn University Hospital in Germany, and a member of the Diversity @ DRG Commission. Her interest in gender diversity led to her contribution to a 2018 special report entitled “Women in radiology: gender diversity is not a metric—it is a tool for excellence”, published by European Radiology.

    In today’s conversation, you’ll hear about the positive influence of a diverse workforce within the healthcare sector. Professor Attenberger believes that diversity allows us to embrace dimensionality, and shares how this reflects positively in the workplace. She also reveals the ways in which inclusivity can be achieved through organizational reforms, and how it has the capacity to benefit physicians as well as patients. 

    Some Questions Asked:
    What is diversity and inclusion for you? (2:15)How should physicians take diversity into account in their work and training? (10:46)What can be done to increase the representation of women in leadership? (15:22)How do you foster inclusion at the University Hospital in Bonn, and in medicine as a whole? (22:38)
    What You’ll Learn in This Episode:
    The dangers of homogeneous healthcare (4:49)The most important aspect of building a successful team (7:35) What we know about unconscious bias (13:23)Ideas about how we can close the gap on gender-based career obstacles (19:25)
    Connect with Ulrike Attenberger:
    University Hospital Bonn
    Connect with our Managing Board Member, Christoph Zindel: 
     LinkedIn
    See acast.com/privacy for privacy and opt-out information.

    • 33 min
    Understanding Immunity: How Antibody Testing for SARS-CoV-2 Works and What We Can Learn from it with Dr. Angela Rasmussen and the Mizzou Antibody Testing Team | Deepak Nath

    Understanding Immunity: How Antibody Testing for SARS-CoV-2 Works and What We Can Learn from it with Dr. Angela Rasmussen and the Mizzou Antibody Testing Team | Deepak Nath

    It’s just over one year since COVID-19 became a familiar term around the world. Due to quick action and collaborative innovation from science and medicine, vaccines have been developed and are being distributed at a pace unrivaled in human history. But, the work doesn’t stop there.

    Regularly monitoring vaccine efficacy and surveying human behavior among the vaccinated population are crucial to understanding its durability. Antibody testing will continue to be important, long after vaccines have been administered.

    Our guest today is Dr. Angela Rasmussen, a virologist and affiliate of the Georgetown Center for Global Health, Science and Security. She collects evidence about the human response to emerging viruses to gain a better understanding of vaccine efficacy.
     
    Today we’re discussing all aspects of antibody testing for SARS-CoV-2. We’ll learn how the tests are implemented, how they determine an immune response is present, and why testing for antibodies is such an important part of the battle against this virus.
     
    We’ll also hear from University of Missouri (MU) scientists Dr. Mark Daniels, Professor of Immunology, Dr. John R. Middleton, Professor of Livestock Health, and Dr. Enid Schatz, chair of the Department of Public Health. The university is conducting an antibody testing study – both biological and behavioral – and our experts on the ground at MU will walk us through the antibody testing process from start to finish.
     
    Some Questions Asked:
    How can testing help us continue to research and improve vaccine use alongside their distribution? (2:42)
    What does an ideal testing scenario look like? (4:21)
    Which behaviors can be more easily changed, and which might be more challenging to shift? (12:13)
    When do you think people can expect to return to business as usual? (16:19)
     
    What You’ll Learn in This Episode:
    Why it’s hard to determine post-vaccination behavior recommendations (1:30)
    The importance of following the progress of vaccinated individuals (3:26)
    How antibody testing works at the University of Missouri (6:56)
    What we can learn from collecting behavioral data (10:27)
    Discoveries that were made about antibody levels (13:58)
    Why it’s important to invest in research now (18:51)
     
    Learn more about Dr. Angela Rasmussen:
    Website
    Twitter
     
    Learn more about Dr. Mark Daniels
    MU School of Medicine
    LinkedIn
     Learn more about Dr. John R. Middleton
    MU College of Veterinary Medicine
     
    Learn more about Dr. Enid Schatz:MU School of Health Professions
    LinkedIn

    Connect with President of Laboratory Diagnostics, Deepak Nath:
    LinkedIn
    Twitter


    See acast.com/privacy for privacy and opt-out information.

    • 20 min

Customer Reviews

4.9 out of 5
8 Ratings

8 Ratings

Stephan 124736351 ,

Great Insights!

Industry champion Siemens Healthineers meets global thought leaders in their respective disciplines - fantastic content for all that are interested in a future vision of healthcare and the healthcare business in general!

Top Podcasts In Science

You Might Also Like